These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21059303)

  • 21. Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
    Liu CH; Liang CC; Liu CJ; Tsai HB; Hung PH; Hsu SJ; Chen SI; Lin JW; Lai MY; Chen JH; Chen PJ; Chen DS; Kao JH
    Gut; 2009 Feb; 58(2):314-6. PubMed ID: 19136527
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin.
    Varghese R; Al-Khaldi J; Asker H; Fadili AA; Al Ali J; Hassan FA
    Hepatogastroenterology; 2009; 56(89):218-22. PubMed ID: 19453061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of peginterferon α-2a and α-2b for treatment-naive patients with chronic hepatitis C virus: A meta-analysis of randomized trials.
    Zhao S; Liu E; Chen P; Cheng D; Lu S; Yu Q; Wang Y; Wei K; Yang P
    Clin Ther; 2010 Aug; 32(9):1565-77. PubMed ID: 20974315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An open-label pilot study evaluating the efficacy and safety of peginterferon alfa-2a combined with ribavirin in children with chronic hepatitis C].
    Zhang HF; Yang XJ; Zhu SS; Dong Y; Chen DW; Jia WZ; Xu ZQ; Mao YL; Tang HM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):185-7. PubMed ID: 16027794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A success story with chronic hepatitis C.
    Weekley D; Yuen JC
    J Ark Med Soc; 2005 Dec; 102(6):158-9. PubMed ID: 16381402
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.
    Slavenburg S; Drenth JP
    Nephrol Dial Transplant; 2008 Jul; 23(7):2430; author reply 2430-1. PubMed ID: 18400821
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing the current therapy for chronic hepatitis C virus: peginterferon and ribavirin dosing and the utility of growth factors.
    Shiffman ML
    Clin Liver Dis; 2008 Aug; 12(3):487-505, vii. PubMed ID: 18625425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peginterferon and ribavirin for hepatitis C.
    Assy N; Embon O
    N Engl J Med; 2007 Mar; 356(12):1269; author reply 1271. PubMed ID: 17380576
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of infection due to hepatitis C virus in haemodialysis].
    Hidalgo-Collazos P; Marín-Ventura L; Sánchez R; García-López L; Criado-Illana MT
    Nefrologia; 2014; 34(1):132-3. PubMed ID: 24463875
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C.
    Hadziyannis SJ; Sevastianos V
    Aliment Pharmacol Ther; 2013 Feb; 37(4):491. PubMed ID: 23336678
    [No Abstract]   [Full Text] [Related]  

  • 31. Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.
    Sherman M; Yoshida EM; Deschenes M; Krajden M; Bain VG; Peltekian K; Anderson F; Kaita K; Simonyi S; Balshaw R; Lee SS;
    Gut; 2006 Nov; 55(11):1631-8. PubMed ID: 16709661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The treatment of viral hepatitis, present and future.
    Rodés J
    J Hepatobiliary Pancreat Surg; 2003; 10(2):163-7. PubMed ID: 14505150
    [No Abstract]   [Full Text] [Related]  

  • 33. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
    Di Bisceglie AM; Ghalib RH; Hamzeh FM; Rustgi VK
    J Viral Hepat; 2007 Oct; 14(10):721-9. PubMed ID: 17875007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin.
    Fried MW; Hadziyannis SJ
    Semin Liver Dis; 2004; 24 Suppl 2():47-54. PubMed ID: 15346246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pegylated interferon treatments for chronic active hepatitis C on quality of life.
    Nayman Alpat S; Usluer G; Yavuz H; Doyuk Kartal E; Erben N; Bal C; Ozgunes I
    J Chemother; 2008 Feb; 20(1):101-5. PubMed ID: 18343751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
    Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
    J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin.
    Berg C; Goncales FL; Bernstein DE; Sette H; Rasenack J; Diago M; Jensen DM; Graham P; Cooksley G
    J Viral Hepat; 2006 Jul; 13(7):435-40. PubMed ID: 16792536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial: pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon alpha-2a in hepatitis C virus genotype 1 true non-responder patients.
    Diago M; Crespo J; Olveira A; Pérez R; Bárcena R; Sánchez-Tapias JM; Muñoz-Sánchez M; Romero-Gómez M
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1131-8. PubMed ID: 17894655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.
    Ferenci P; Formann E; Laferl H; Gschwantler M; Hackl F; Brunner H; Hubmann R; Datz C; Stauber R; Steindl-Munda P; Kessler HH; Klingler A; Gangl A;
    J Hepatol; 2006 Feb; 44(2):275-82. PubMed ID: 16338019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful desensitization to ribavirin in a patient with chronic hepatitis C.
    Ladd AM; Martel-Laferriere V; Dieterich D
    J Clin Gastroenterol; 2012 Sep; 46(8):716-7. PubMed ID: 22739224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.